X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/10/19/2762896/0/en/Actimed-Therapeutics-Appoints-Martin-Walton-as-Chief-Financial-Officer.html
https://www.globenewswire.com//news-release/2023/09/07/2739001/0/en/Actimed-Therapeutics-announces-FDA-approval-of-its-Investigational-New-Drug-application-for-Phase-2b-3-IMPACT-clinical-trials-of-S-pindolol-benzoate-to-treat-cancer-cachexia.html
https://www.globenewswire.com/news-release/2023/06/26/2694141/0/en/Actimed-Therapeutics-closes-over-subscribed-Series-A-Financing-Round-of-5-million-to-advance-clinical-development-of-lead-programme-for-cancer-cachexia.html
https://www.prnewswire.com/news-releases/actimed-therapeutics-successfully-closes-second-tranche-of-10m-seed-financing-to-progress-pipeline-for-treatment-of-cancer-cachexia-and-other-muscle-wasting-disorders-301712612.html
https://www.prnewswire.com/news-releases/actimed-therapeutics-continues-to-strengthen-intellectual-property-portfolio-with-newly-granted-us-and-canadian-patents-301398462.html
https://www.prnewswire.com/news-releases/actimed-therapeutics-announces-successful-closing-of-2-5m-extended-seed-b-funding-round-301309203.html
https://www.prnewswire.com/news-releases/actimed-therapeutics-and-faraday-pharmaceuticals-announce-license-agreement-for-s-oxprenolol-301266932.html
https://www.prnewswire.com/news-releases/actimed-therapeutics-and-faraday-pharmaceuticals-announce-license-agreement-for-s-oxprenolol-301266932.html
Market Place
Share 
